| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ea8218229ca8b5cbe08dac8f9efd6f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b1bde42c95726a1a0dd1d6f7188b5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5b224e91913c08e9857577d1173379d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
2012-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b7391cdf5df652100242659761806a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44d16c444fc1a5ec77de9bbffdbc89f5 |
| publicationDate |
2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012175747-A1 |
| titleOfInvention |
Production method and dosage form |
| abstract |
The invention relates to a production method for dosage forms. The production method makes dosage forms accessible that help even active ingredients that are poorly soluble to be highly bioavailable when taken orally. Another important advantage of the method is that the dosage forms produced in such a manner have good storage stability. The dosage forms produced in such a manner comprise several subunits. The invention further relates to the dosage forms and to uses of the dosage forms. In particular, the invention relates to layered tablets and to capsules that contain powder and coated microtablets. Examples of active ingredients are cinnarizine and dimenhydrinate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-028064-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-035815-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102160837-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150041612-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013283474-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2959887-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014001268-A1 |
| priorityDate |
2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |